| NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition M Hinz, D Krappmann, A Eichten, A Heder, C Scheidereit, M Strauss Molecular and cellular biology, 1999 | 1155 | 1999 |
| Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. RC Bargou, F Emmerich, D Krappmann, K Bommert, MY Mapara, ... The Journal of clinical investigation 100 (12), 2961-2969, 1997 | 1000 | 1997 |
| Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia SA Slaugenhaupt, A Blumenfeld, SP Gill, M Leyne, J Mull, MP Cuajungco, ... The American Journal of Human Genetics 68 (3), 598-605, 2001 | 665 | 2001 |
| OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin K Keusekotten, PR Elliott, L Glockner, BK Fiil, RB Damgaard, Y Kulathu, ... Cell 153 (6), 1312-1326, 2013 | 476 | 2013 |
| NF-κB and the innate immune response EN Hatada, D Krappmann, C Scheidereit Current opinion in immunology 12 (1), 52-58, 2000 | 472 | 2000 |
| Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-κB S Mathas, M Hinz, I Anagnostopoulos, D Krappmann, A Lietz, F Jundt, ... The EMBO journal 21 (15), 4104-4113, 2002 | 460 | 2002 |
| High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells RC Bargou, C Leng, D Krappmann, F Emmerich, MY Mapara, K Bommert, ... | 422 | 1996 |
| Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells D Krappmann, F Emmerich, U Kordes, E Scharschmidt, B Dörken, ... Oncogene 18 (4), 943-953, 1999 | 368 | 1999 |
| Overexpression of I kappa B alpha without inhibition of NF-κB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells F Emmerich, M Meiser, M Hummel, G Demel, HD Foss, F Jundt, S Mathas, ... Blood, The Journal of the American Society of Hematology 94 (9), 3129-3134, 1999 | 367 | 1999 |
| Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells U Kordes, D Krappmann, V Heissmeyer, WD Ludwig, C Scheidereit Leukemia 14 (3), 399-402, 2000 | 362 | 2000 |
| The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation FG Wulczyn, D Krappmann, C Scheidereit Journal of Molecular Medicine 74, 749-769, 1996 | 358 | 1996 |
| Nuclear factor κB–dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of … M Hinz, P Lemke, I Anagnostopoulos, C Hacker, D Krappmann, S Mathas, ... The Journal of experimental medicine 196 (5), 605-617, 2002 | 351 | 2002 |
| Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells M Hinz, P Löser, S Mathas, D Krappmann, B Dörken, C Scheidereit Blood, The Journal of the American Society of Hematology 97 (9), 2798-2807, 2001 | 347 | 2001 |
| Purification and characterization of the human elongator complex NA Hawkes, G Otero, GS Winkler, N Marshall, ME Dahmus, D Krappmann, ... Journal of Biological Chemistry 277 (4), 3047-3052, 2002 | 302 | 2002 |
| The let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2 A Rybak, H Fuchs, K Hadian, L Smirnova, EA Wulczyn, G Michel, R Nitsch, ... Nature cell biology 11 (12), 1411-1420, 2009 | 293 | 2009 |
| Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote TH17 differentiation KM Jeltsch, D Hu, S Brenner, J Zöller, GA Heinz, D Nagel, KU Vogel, ... Nature immunology 15 (11), 1079-1089, 2014 | 292 | 2014 |
| NF-κB p105 is a target of IκB kinases and controls signal induction of Bcl-3–p50 complexes V Heissmeyer, D Krappmann, FG Wulczyn, C Scheidereit The EMBO journal 18 (17), 4766-4778, 1999 | 281 | 1999 |
| Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation M Broemer, D Krappmann, C Scheidereit Oncogene 23 (31), 5378-5386, 2004 | 277 | 2004 |
| A20 negatively regulates T cell receptor signaling to NF-κB by cleaving Malt1 ubiquitin chains M Düwel, V Welteke, A Oeckinghaus, M Baens, B Kloo, U Ferch, ... The journal of immunology 182 (12), 7718-7728, 2009 | 266 | 2009 |
| Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL D Nagel, S Spranger, M Vincendeau, M Grau, S Raffegerst, B Kloo, ... Cancer cell 22 (6), 825-837, 2012 | 260 | 2012 |
Claus ScheidereitMax-Delbrück-Centrum, MDCVerified email at mdc-berlin.de
